Human liver stem cells improve liver injury in a model of fulminant liver failure
- 1 January 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 57 (1) , 311-319
Abstract
Liver transplantation is currently the only effective therapy for fulminant liver failure, but its use is limited by the scarcity of organs for transplantation, high costs, and lifelong immunosuppression. Here we investigated whether human liver stem cells (HLSCs) protect from death in a lethal model of fulminant liver failure induced by intraperitoneal injection of D-galactosamine and lipopolysaccharide in SCID mice. We show that injection of HLSCs and of HLSC-conditioned medium (CM) significantly attenuates mouse mortality in this model. Histopathological analysis of liver tissue showed reduction of liver apoptosis and enhancement of liver regeneration. By optical imaging we observed a preferential localization of labeled HLSCs within the liver. HLSCs were detected by immunohistochemistry in large liver vessels (at 24 hours) and in the liver parenchyma (after day 3). Fluorescence in situ hybridization analysis with the human pan-centromeric probe showed that positive cells were cytokeratin-negative at 24 hours. Coexpression of cytokeratin and human chromosome was observed at 7 and, to a lesser extent, at 21 days. HLSC-derived CM mimicked the effect of HLSCs in vivo. Composition analysis of the HLSC-CM revealed the presence of growth factors and cytokines with liver regenerative properties. In vitro experiments showed that HLSC-CM protected human hepatocytes from apoptosis and enhanced their proliferation. Conclusion: These data suggest that fulminant liver failure may potentially benefit from treatment with HLSCs or HLSC-CM. (Hepatology 2013)Keywords
This publication has 23 references indexed in Scilit:
- Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Hepatic Ischemia Reperfusion Injury in a Rat ModelPLOS ONE, 2011
- Stem and progenitor cells in liver regeneration and repairCytotherapy, 2011
- Human liver stem cell‐derived microvesicles accelerate hepatic regeneration in hepatectomized ratsJournal of Cellular and Molecular Medicine, 2010
- The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liverNature Protocols, 2010
- Differentiation of Bone Marrow-derived Mesenchymal Stem Cells into Hepatocyte-like Cells on Nanofibers and Their Transplantation into a Carbon Tetrachloride-Induced Liver Fibrosis ModelStem Cell Reviews and Reports, 2010
- Stem cells, cell transplantation and liver repopulationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic FailurePLOS ONE, 2007
- Isolation and Characterization of a Stem Cell Population from Adult Human LiverStem Cells, 2006
- Cell choice for bioartificial livers.The Keio Journal of Medicine, 2003
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.Journal of Experimental Medicine, 1987